Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction
Open Access
- 10 August 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (16) , 19891-19917
Abstract
Chronic neuroinflammation and cholinergic dysfunction are major contributors to cognitive decline in Alzheimer’s disease. Here, we report a series of pyridazine-based multitarget-directed ligands that simultaneously inhibit human butyrylcholinesterase (hBChE) and p38α mitogen-activated protein kinase (p38α MAPK). Pyridazines 8 and 21 were identified as potent dual inhibitors with submicromolar inhibitory potencies against target enzymes and high selectivity over acetylcholinesterase. X-ray crystallographic analyses revealed the experimental binding modes of 8 and 21 in hBChE and p38α MAPK, and identified conserved π–π, π–cation, and hinge region interactions that rationalize dual-target engagement. Both compounds were blood-brain barrier permeable, exhibited low cytotoxicity, and significantly attenuated lipopolysaccharide-induced proinflammatory responses and apoptosis in BV2 microglia. In vivo, compound 21 enhanced cognitive performance in mouse models of scopolamine-induced amnesia and LPS-stimulated neuroinflammatory cognitive impairment. Collectively, these results document the potential of structure-assisted design to achieve selective dual-target pharmacology within a single molecular entity.Keywords
Funding Information
- National Institute on Aging (AG043415)
- National Institute on Aging (AG062095)
- Uniwersytet Jagielloński Collegium Medicum (N42/DBS/000454)
- Univerzita Hradec Králové (2206/2025-2026)
- Grantová Agentura České Republiky (GF23-42701L)
- Ministerstvo Zdravotnictví Ceské Republiky (UHHK, 00179906)
- Narodowe Centrum Nauki (DEC-2021/43/I/NZ7/00342)
- The Slovenian Research and Innovation Agency (N1-0277)
- The Slovenian Research and Innovation Agency (P1-0208)
- The Slovenian Research and Innovation Agency (P4-0127)
- Univerza v Ljubljani (NA)
- European Regional Development Fund (NA)
- Ministère des Armées (NBC-5-C-2316)
- Graduate Program in Physics at UNIFAL-MG (BI-FR/23-24-PROTEUS-002)
- Graduate Program in Physics at UNIFAL-MG (NA)
This publication has 101 references indexed in Scilit:
- Dementia Prevention and TreatmentJAMA Internal Medicine, 2024
- Low‐grade systemic inflammation stimulates microglial turnover and accelerates the onset of Alzheimer's‐like pathologyGlia, 2024
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementiaCochrane Database of Systematic Reviews, 2021
- Cholinesterase as a Target for Drug Development in Alzheimer’s Disease2019
- MolProbity: More and better reference data for improved all‐atom structure validationProtein Science, 2017
- Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2013
- A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentPsychopharmacology, 2011
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- Cholinergic function and Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2003
- β-Amyloid-Induced Inflammation and Cholinergic Hypofunction in the Rat Brain in Vivo: Involvement of the p38MAPK PathwayNeurobiology of Disease, 2002